Tumor infiltrating lymphocytes

Show results for

Unknown (3340)
Genomics (609)
Transcriptomics (424)
Proteomics (45)
Other (28)
Clinical (11)
Methylation profiling (7)
Metabolomics (2)
Models (1)
Genomic (1)

Organisms

Homo sapiens (305)
Mus musculus (238)
Andropogon gerardi (33)
Bacteria (33)
Canis lupus familiaris (33)
Chromatiales bacterium OalgGamma1 (33)
Clavibacter nebraskensis NCPPB 2581 (33)
Cnidaria (33)
Ensifer adhaerens (33)
Fasciola (33)
Human alphaherpesvirus 1 strain 17 (33)
Human alphaherpesvirus 1 strain KOS (33)
Human betaherpesvirus 5 (33)
Human herpesvirus 2 strain 186 (33)
synthetic construct (3)
Rattus norvegicus (2)
Thermoplasma acidophilum DSM 1728 (1)
Viruses (1)
Cytomegalovirus (1)
Betapolyomavirus hominis (1)
Betapolyomavirus macacae (1)
Merkel cell polyomavirus (1)
Rhadinovirus (1)
Lymphocryptovirus (1)
Human alphaherpesvirus 2 (1)
JC polyomavirus (1)
Human alphaherpesvirus 1 (1)
Human immunodeficiency virus 1 (1)
Human betaherpesvirus 5 (1)
Murid gammaherpesvirus 4 (1)

Organisms

Homo sapiens (235)
Mus musculus (222)
unidentified (1)

Repository

ENA (537)
geo (375)
biostudies-arrayexpress (114)
EGA (44)
pride (33)
jPOST (5)
MassIVE (3)
iProX (2)
MetaboLights (2)
BioModels (1)
dbGaP (1)

Tissue

T cell (8)
Cell culture (6)
Spleen (5)
Epithelial cell (3)
B cell (2)
Cytotoxic T-lymphocyte (2)
Epithelial ovarian cancer cell (2)
Melanocyte (2)
Ovarian serous carcinoma cell (2)
Skin (2)
Acinar cell (1)
B-lymphoblastoma cell (1)
Blood (1)
Brain (1)
Breast (1)
Breast cancer cell (1)
Breast epithelium (1)
Colorectal adenocarcinoma cell line (1)
HeLa cell (1)
Leukocyte (1)
Lung (1)
Macrophage (1)
MiaPaCa-2 cell (1)
Mucosal melanoma cell (1)
Pancreas (1)
Pancreatic cancer cell line (1)
Permanent cell line cell (1)
SW-620 cell (1)
Stromal cell (1)
T-lymphocyte cell line (1)

Disease

Breast cancer (5)
Colorectal Neoplasms (4)
Melanoma (3)
Pre diabetic (2)
Malignant neoplasm of ovary (2)
4T1 tumor-bearing (1)
Invasive Ductal Carcinoma (1)
Glioblastoma multiforme (1)
Urogenital Neoplasms (1)
Colorectal liver metastases (1)
Mesothelioma (1)
Breast Neoplasms (1)
Lung Neoplasms (1)
Carcinoma (1)
Colorectal cancer (1)
Brain glioblastoma multiforme (1)
Cervix carcinoma (1)
Colon cancer (1)
Cutaneous malignant melanoma 1 (1)
Endometrial cancer (1)
Lung cancer (1)
Non-small cell lung carcinoma (1)
Ovarian serous carcinoma (1)
Pancreatic cancer (1)
Uveal melanoma (1)

Technology Type

Mass Spectrometry (33)
Shotgun proteomics (16)
Bottom-up proteomics (8)
Affinity purification coupled with mass spectrometry proteomics (5)
Data-independent acquisition (4)
Illumina HiSeq 2000 (3)
Data-dependent acquisition (3)
Top-down proteomics (3)
Mass spectrometry (2)
NextSeq 500, ILLUMINA (1)
Illumina HiSeq 2500 (ILLUMINA), Illumina HiSeq 4000 (ILLUMINA) (1)
Illumina HiSeq 2500, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HiSeq 4000, Illumina HiSeq 2500, ILLUMINA (1)
Illumina HiSeq 2000, HumanMethylation450k Bead Chip - Genome Studio, Illumina Genome Analyzer IIx (1)
SWATH MS (1)

Instrument Platform

NextSeq 500 (6)
Illumina MiSeq (4)
Illumina NovaSeq 6000 (4)
Agilent G2565AA and G2565BA Microarray Scanner (2)
NextSeq 2000 (2)
DNBSEQ-T7 (2)
Illumina HiSeq 2000 (2)
Illumina HiSeq 4000 (2)
ProFlex PCR system (1)
Heraeus SEPATECH (1)
Nucleospin® Extract II (1)
Qubit (1)
Hybridization Chamber, stainless,Hybridization oven rotator (1)
Flow Cytometry (1)
Agilent Technologies Scanner G2505C (1)
Axon- GenePix4000B (1)
NextSeq 1000 (1)
Illumina NovaSeq X (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
LTQ Orbitrap Velos (1)
Orbitrap Eclipse (1)
Q-Exactive (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (68)
2024 (61)
2023 (56)
2026 (46)
2021 (41)
2020 (31)
2022 (31)
2017 (27)
2019 (25)
2018 (23)
2016 (23)
2015 (22)
2012 (16)
2014 (14)
2010 (14)
2013 (12)
2008 (6)
2007 (5)
2011 (3)
2009 (3)
2006 (2)
2005 (2)

CHEBI ID

CHEBI:190663 (1)
CHEBI:164781 (1)
CHEBI:159767 (1)
CHEBI:194292 (1)
CHEBI:161812 (1)
CHEBI:158783 (1)
CHEBI:194290 (1)
CHEBI:194289 (1)
CHEBI:194284 (1)
CHEBI:194280 (1)
CHEBI:161337 (1)
CHEBI:194276 (1)
CHEBI:194264 (1)
CHEBI:68747 (1)
CHEBI:194277 (1)
CHEBI:194271 (1)
CHEBI:190673 (1)
CHEBI:194262 (1)
CHEBI:194255 (1)
CHEBI:194251 (1)
CHEBI:89100 (1)
CHEBI:194293 (1)
CHEBI:194254 (1)
CHEBI:182582 (1)
CHEBI:194267 (1)
CHEBI:194288 (1)
CHEBI:194266 (1)
CHEBI:194252 (1)
CHEBI:131660 (1)
CHEBI:170052 (1)

Metabolite Name

2'-Deoxyadenosine (2)
S-Lactoylglutathione (2)
N6,N6,N6-Trimethyl-L-lysine (2)
Trigonelline (2)
Thr-Leu (2)
Thiamine (2)
Guanine (2)
Nicotinic Acid (2)
Cytarabine (2)
N-Acetylglycine (2)
7-Ketocholesterol (2)
Spermidine (2)
Phosphocholine (2)
Acetylcholine (2)
Nicotinamide (2)
Choline (2)
Cys-Gly (2)
Methyltestosterone (2)
Ala-Val (2)
Adenosine (2)
Vindoline (2)
Riboflavin (2)
L-Histidine (2)
Uracil (2)
Thymine (2)
Gly-Phe (2)
Creatine (2)
L-Tyrosine (2)
1-Methyladenosine (2)
L-Phenylalanine (2)

IsPrivate

False (1)

First Public Date

2025 (81)
2024 (75)
2026 (69)
2023 (66)
2021 (61)
2022 (41)
2019 (30)
2020 (26)
2017 (24)
2018 (23)
2016 (17)
2014 (16)
2015 (8)

Modelling Approach

Ordinary differential equation model (1)

Study status

Recruiting (4)
Completed (4)
Not provided (2)
Active, not recruiting (1)

Study type

Transcription profiling by array (76)
RNA-seq of coding RNA (15)
RNA-seq of coding RNA from single cells (10)
Interventional (7)
Unknown experiment type (5)
Observational (4)
Comparative genomic hybridization by array (3)
Human - High-throughput sequencing (1)
Single nucleus RNA sequencing (1)
MicroRNA profiling by array (1)
Proteomic profiling by array (1)
RNA-seq of total RNA (1)

Release Date

2022 (484)
2021 (448)
2023 (442)
2020 (342)
2025 (339)
2024 (317)
2019 (241)
2018 (208)
2016 (154)
2017 (144)
2015 (88)
2014 (57)
2026 (37)
2012 (34)
2013 (33)
2011 (22)
2010 (22)
2008 (8)
2009 (7)
2007 (7)
2005 (5)
2004 (4)
2006 (3)
2002 (3)
2003 (2)
2001 (2)
2000 (1)

Lab affiliation

Departments of Immunology and Radiation Oncology Moffitt Cancer Center Tampa, FL, USA (2)
Director of Women’s Health Research Women’s Service Line Inova Health System (2)
Department of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA (1)
Department of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, USA. (1)
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (1)
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel (1)
European Institute of Oncology (1)
Genecology Research Centre, University of the Sunshine Coast, Maroochydore DC, QLD 4558, Australia (1)
Immunology Moffitt Cancer Center Tampa, FL, USA (1)
Immunology and Radiation Oncology Moffitt Cancer Center Tampa, FL, USA (1)
Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Barcelona, Spain. (1)
Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona 08010, Spain (1)
Institute of Biological Chemistry (1)
Laboratory of Molecular Pharmacology and Drug Discovery, Institute of Chinese Materia Medica, The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518033, China (1)
Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland (1)
Molecular Cell Biolody, Weizmann Institute of Science. (1)
Molecular cell biology department Weizmann Institute of Science (1)
Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, 8091 Zurich, Switzerland (1)
Nuffield Department of Medicine, University of Oxford, OX3 7FZ, U.K. (1)
PRISM U1192, Universite de Lille France (Lab head) (1)
Professor, Head of Cancer Research, University of Southern Denmark (1)
Proteomics Core Facility, University of Gothenburg, Sweden (1)
Proteomics Service CIC bioGUNE Bizkaia Tech. Park Build. 800 48160 Derio Spain (1)
Proteomics Service CIC bioGUNE Bizkaia Tech. Park Build. 800 Derio 48160 Spain (1)
Proteomics Unit (UCCTs), Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain (1)
Proteomics, Beatson Institute for Cancer Research, Glasgow,UK (1)
Thoracic Oncology Moffitt Cancer Center Tampa, FL, USA (1)
Unit of Chemical Proteomics, Division of Chemistry I, Dept. of Medical Biochemistry and Biophysics (MBB), Karolnska Institutet, Biomedicum, Solna, Sweden (1)
University of California San Diego (1)
University of Pavol Jozef Šafárik in Košice (1)

Location

United States (6)
Japan (2)
China (1)
France (1)
Switzerland (1)

Keyword

Fludarabine (3)
Cyclophosphamide (3)
Pembrolizumab (2)
Digestive Tract Cancers (1)
Endocrine Tumors (1)
Ovarian/Endometrial Cancer (1)
NT-I7 (Efineptakin alfa) (1)
Non-small Cell Lung (1)
Small Cell Lung (1)
Programmed cell death protein (PD-1) (1)
Oncolytic Vaccinia Virus (1)
Tumor Cell Death (1)
Viral Therapy (1)
Anti-Tumor Immunity (1)
Genitourinary Cancer (1)
Solid Malignancies (1)
Adoptive Cell Therapy (ACT) (1)
TIL (1)
Mitogens (1)
Breast (1)
Aldesleukin (1)
Tremelimumab (1)
Thoracic Neoplasms (1)
T cell (1)
Interleukin 7 (1)
PD-1 (1)
Pancreas (1)
Lung (1)
Interleukin-2 (1)
Colorectal (1)

Previous page
1 / 447
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 447
Next page

Sort by:

Relevance

Page size

Non-cancerous liver infiltrating lymphocytes of hepatitis C and tumor-infiltrating lymphocytes

Study goal is to disclose features of gene expressio profile of non-cancerous liver-infiltrating lymphocytes of type C hepatitis patients with hepatocellular carcinomas and tumor-infiltrating lymphocytes of type C hepatitis patients with hepatocellular carcinomas. Keywords: gene expression profile,...

ORGANISM(S): Homo sapiens

2010-06-25 | E-GEOD-10461 | biostudies-arrayexpress

Extracellular-acidosis restricts one-carbon metabolism and preserves T cell stemness

The accumulation of acidic metabolic waste products within the tumor microenvironment profoundly inhibits effector functions of tumor-infiltrating lymphocytes (TILs). However, it is unclear whether extracellular-acidosis impacts T cell metabolic fitness and differentiation status. Here, we surprisin...

2023-01-17 | MTBLS6661 | MetaboLights

Transcription profiling of human T cell lines isolated from tumor infiltrating lymphocytes or peripheral blood lymphocytes of a patient with large cell carcinoma of the lung

The IGR-Heu tumor cell line was established from patient Heu suffering from large cell carcinoma of the lung. Heu171, Heu127 and Heu161 T cell clones were isolated from autologous tumor infiltrating lymphocytes. H32 T cell line and H32-22 clone were isolated from autologous PBL after stimulation wit...

ORGANISM(S): Homo sapiens

2007-03-02 | E-TABM-208 | biostudies-arrayexpress

Transcription profiling of human T cell lines isolated from tumor infiltrating lymphocytes or peripheral blood lymphocytes of a patient with large cell carcinoma of the lung

The IGR-Heu tumor cell line was established from patient Heu suffering from large cell carcinoma of the lung. Heu171 T cell clones were isolated from autologous tumor infiltrating lymphocytes. H32-22 clone was isolated from autologous peripheral blood lymphocytes after stimulation with IGR-Heu and...

ORGANISM(S): Homo sapiens

2007-03-02 | E-TABM-207 | biostudies-arrayexpress

CD8+/CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients

We had previously demonstrated the role of CD103 integrin on lung tumor-infiltrating lymphocyte (TIL) clones in promoting specific TCR-mediated epithelial tumor cell cytotoxicity. However, the contribution of CD103 on intratumoral T-cell distribution and functions, and the prognosis significance of ...

ORGANISM(S): Homo sapiens

2015-06-29 | E-MTAB-3266 | biostudies-arrayexpress

CD8+ Tumor-Infiltrating Lymphocyte Abundance is a Positive Prognostic Indicator in Nasopharyngeal Cancer

A retrospective tissue study to explore the prognostic significance of tumor-infiltrating lymphocyte (TIL) populations in Nasopharyngeal Cancer, using a combination of RNA sequencing and immunohistochemistry.

ORGANISM(S): Homo sapiens

2022-09-01 | E-MTAB-11963 | biostudies-arrayexpress

Evaluation of Tumor Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer

Tumor infiltrating lymphocytes (TILs) play a significant role in the tumor microenvironment in high-grade serous ovarian cancer (HGSOC). To better understand the interactions and functions of TILs in HGSOC progression, we performed proteogenomic profiling of TILs in 65 tumors collected from 12 HGSOC...

ORGANISM(S): Homo sapiens (Human)

2024-03-15 | PXD045710 | Pride

Microbial Peptides Activate Tumor-Infiltrating Lymphocytes in Glioblastoma

Microbial organisms play key roles in numerous physiological processes in the human body and have recently been shown to modify the response to cancer radiotherapy and immune checkpoint inhibitors. Here, we demonstrate that HLA molecules of both glioblastoma tissues as well as tumor cell lines prese...

ORGANISM(S): Homo sapiens (Human)

2023-02-20 | PXD036811 | Pride

Human Glioblastoma Immunopeptidome Hla-dr

Transcriptional profiling by mRNA microarray of pancreas-infiltrating T lymphocytes of NOD mice

Whole mouse genome microarrays from Agilent were used to determine expression profile of pancreas-infiltrating T CD3+ and total T lymphocytes of NOD mice.

ORGANISM(S): Mus musculus

2015-05-29 | E-MTAB-3555 | biostudies-arrayexpress

Transcriptional profiling by microarray of microRNAs of pancreas-infiltrating T lymphocytes from NOD mice

The microRNA oligo microarrays from Agilent were used to determine miRNA expression profile of pancreas-infiltrating T CD3+ and total T lymphocytes of NOD mice.

ORGANISM(S): Mus musculus

2015-05-29 | E-MTAB-3556 | biostudies-arrayexpress

Previous page
1 / 447
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 447
Next page

Sort by:

Relevance

Page size

4468 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

First Public Date

Modelling Approach

Study status

Study type

Release Date

Lab affiliation

Location

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets